Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,156 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of Focal Liver Reaction after Proton Beam Therapy for Hepatocellular Carcinoma Examined Using Gd-EOB-DTPA Enhanced Hepatic Magnetic Resonance Imaging.
Takamatsu S, Yamamoto K, Maeda Y, Kawamura M, Shibata S, Sato Y, Terashima K, Shimizu Y, Tameshige Y, Sasaki M, Asahi S, Kondou T, Kobayashi S, Matsui O, Gabata T. Takamatsu S, et al. Among authors: shibata s. PLoS One. 2016 Dec 1;11(12):e0167155. doi: 10.1371/journal.pone.0167155. eCollection 2016. PLoS One. 2016. PMID: 27907063 Free PMC article.
Respiratory-gated Proton Beam Therapy for Hepatocellular Carcinoma Adjacent to the Gastrointestinal Tract without Fiducial Markers.
Mizuhata M, Takamatsu S, Shibata S, Bou S, Sato Y, Kawamura M, Asahi S, Tameshige Y, Maeda Y, Sasaki M, Kumano T, Kobayashi S, Yamamoto K, Tamamura H, Gabata T. Mizuhata M, et al. Among authors: shibata s. Cancers (Basel). 2018 Feb 21;10(2):58. doi: 10.3390/cancers10020058. Cancers (Basel). 2018. PMID: 29466294 Free PMC article.
Erratum: Shibata S.; et al. Proton Beam Therapy without Fiducial Markers Using Four-Dimensional CT Planning for Large Hepatocellular Carcinomas. Cancers 2018, 10, 71.
Shibata S, Takamatsu S, Yamamoto K, Mizuhata M, Bou S, Sato Y, Kawamura M, Asahi S, Tameshige Y, Maeda Y, Sasaki M, Kumano T, Kobayashi S, Tamamura H, Gabata T. Shibata S, et al. Cancers (Basel). 2018 Dec 11;10(12):508. doi: 10.3390/cancers10120508. Cancers (Basel). 2018. PMID: 30545023 Free PMC article.
Toxicity and clinical outcomes of single-fraction high-dose-rate brachytherapy combined with external beam radiotherapy for high-/very high-risk prostate cancer: A dosimetric analysis of toxicity.
Sakurai T, Takamatsu S, Shibata S, Iwata K, Taka M, Gabata T, Kumano T, Makino T, Mizokami A. Sakurai T, et al. Among authors: shibata s. Jpn J Radiol. 2020 Dec;38(12):1197-1208. doi: 10.1007/s11604-020-01023-2. Epub 2020 Jul 31. Jpn J Radiol. 2020. PMID: 32737768
Incidence and dosimetric predictive factors of late rectal toxicity after low-dose-rate brachytherapy combined with volumetric modulated arc therapy in high-risk prostate cancer at a single institution: Retrospective study.
Sakurai T, Takamatsu S, Shibata S, Taka M, Ishiyama M, Yamazaki M, Kojima H, Mizokami A, Kumano T, Gabata T. Sakurai T, et al. Among authors: shibata s. Brachytherapy. 2021 May-Jun;20(3):584-594. doi: 10.1016/j.brachy.2020.12.004. Epub 2021 Jan 21. Brachytherapy. 2021. PMID: 33485811
Correction to: Toxicity and clinical outcomes of single‑fraction high‑dose‑rate brachytherapy combined with external beam radiotherapy for high‑/very high‑risk prostate cancer: A dosimetric analysis of toxicity.
Sakurai T, Takamatsu S, Shibata S, Iwata K, Taka M, Kumano T, Makino T, Mizokami A, Gabata T. Sakurai T, et al. Among authors: shibata s. Jpn J Radiol. 2021 Apr;39(4):404. doi: 10.1007/s11604-020-01073-6. Jpn J Radiol. 2021. PMID: 33496912 No abstract available.
3,156 results